Gait Analysis Following Total Ankle Replacement and Subtalar Fusion

December 1, 2017 updated by: Istituto Ortopedico Galeazzi

Analysis of Patients Who Underwent Ankle Replacement and Simultaneous Subtalar Fusion by Biomechanical and Clinical Evaluation

Subtalar fusion is commonly performed in post-traumatic subtalar osteoarthritis, rheumatoid arthritis, posterior tibial tendon dysfunction, tarsal coalition and primary subtalar osteoarthritis. Patients with osteoarthritis or severe dysfunction involving both the ankle and the subtalar joint may benefit from an tibiotalocalcaneal fusion (TTC) or an ankle replacement and subtalar fusion. With the development of new prosthetic designs and of surgical techniques, total ankle replacements (TAR) became a reasonable alternative to fusion with functional and quality of life improvements. A gait analysis of patients that underwent TAR and simultaneous subtalar fusion allows to study with precision and reliability the ankle range of motion (ROM). On the contrary, in healthy subjects or in patients that underwent isolated TAR this is not possible because the ankle ROM is influenced by the ROM of the subtalar joint in such a way that it is not possible to analyze the two joints separately. Also, excluding the role of the subtalar joint, it is possible to accurately analyze and compare the consequences on ankle kinematics of two different prosthetic designs.

Study Overview

Detailed Description

Patients who previously have underwent TAR and simultaneous subtalar fusion are retrospectively reviewed. Minimum follow-up after the surgery is 12 months.

Study Type

Observational

Enrollment (Actual)

23

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Milan, Italy, 20161
        • IRCCS Galeazzi Orthopedic Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patients who underwent simoultanous total ankle replacement and subtalar fusion

Description

Inclusion Criteria:

  • Patients who underwent ankle prosthesis (Hintegra ankle system, Zimmer Trabecular Metal Total Ankle) and simultaneous fusion of the subtalar joint with at least 12 months of follow-up willing and capable of adhering to postoperative clinical protocols and functional evaluations and who have signed a specific informed consent form approved by the Ethics Committee
  • Males or females aged between 20 and 80 years old.
  • Patients with diagnosis of primary not-inflammatory degenerative articular disease

Exclusion Criteria:

  • Patients with Body Mass Index (BMI)> 35.
  • Patients with active or suspected latent periprosthetic infection
  • Patients who underwent revision surgery.
  • Prosthesis of the hip, knee or ankle, homolateral or contralateral.
  • Fusion failure of subtalar joint.
  • Patients with chronic heart failure (NYHA stage> 2)
  • Presence of neurological disorders, neuromuscular disorders or other major musculoskeletal pathologies
  • Cognitive deficits.
  • Impossibility to match questionnaires due to cognitive disorders or language dysfunctional disorders

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Case-Control
  • Time Perspectives: Cross-Sectional

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Lateral approach group
TAR through lateral approach and subtalar fusion
Simultaneous total ankle replacement through lateral approach and subtalar fusion
Other Names:
  • Zimmer TM (Trabecular Metal ) Total Ankle
Anterior approach group
TAR through anterior approach and subtalar fusion
Simultaneous total ankle replacement through anterior approach and subtalar fusion
Other Names:
  • Hintegra ankle system

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Gait analysis
Time Frame: 1 day
Differences in functional scores obtained by Mini-lab stereophotogrammetry-based Gait Analysis for Lower Limbs
1 day

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
VAS (Visual Analog Scale)
Time Frame: 1 day
Differences in Pain Scores on the Visual Analog Scale
1 day
AOFAS
Time Frame: 1 day
Differences in Functional Scores on the American Orthopaedic Foot and Ankle Society Score
1 day
Short Form Health Survey (SF-12)
Time Frame: 1 day
Differences in Health Scores on the 12-Item Short Form Health Survey
1 day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 16, 2017

Primary Completion (Actual)

June 29, 2017

Study Completion (Actual)

June 29, 2017

Study Registration Dates

First Submitted

November 19, 2017

First Submitted That Met QC Criteria

November 23, 2017

First Posted (Actual)

November 29, 2017

Study Record Updates

Last Update Posted (Actual)

December 4, 2017

Last Update Submitted That Met QC Criteria

December 1, 2017

Last Verified

November 1, 2017

More Information

Terms related to this study

Other Study ID Numbers

  • MAT

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe